Expanding macaque breeding facilities to support HIV research
Novel Macaque Breeding Runs at the New Iberia Research Center
The New Iberia Research Center is building new homes for macaques to help with important research on HIV/AIDS, including finding vaccines and treatments, so they can have enough monkeys for their studies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisiana at Lafayette NIH-funded |
| Lab location | 1 site (Lafayette, United States) |
| Project ID | NIH-10374603 on NIH RePORTER |
What this research studies
The New Iberia Research Center at the University of Louisiana at Lafayette is enhancing its capacity to breed macaques by constructing two specialized housing buildings. These buildings will provide essential amenities such as electricity, water, heating, and air circulation, designed specifically for the needs of macaques. This expansion aims to support ongoing research programs focused on HIV/AIDS, including vaccine development and therapeutic approaches. By increasing the number of breeding animals, the center will ensure a steady supply of macaques for critical research initiatives.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals involved in HIV/AIDS research or those requiring animal models for related studies.
Not a fit: Patients not involved in HIV/AIDS research or those who do not require animal models for their studies may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to advancements in HIV treatment and prevention strategies.
How similar studies have performed: Similar research approaches have shown success in enhancing breeding facilities for research purposes, particularly in the context of HIV/AIDS studies.
Where this research is happening
Lafayette, United States
- University of Louisiana at Lafayette — Lafayette, United States (Active)
Researchers
- Principal investigator: Villinger, Francois J — University of Louisiana at Lafayette
- Study coordinator: Villinger, Francois J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.